The interim final rule would amend FDAs informed consent regulation to provide an exception to the general requirement to obtain informed consent from the subject of an investigation involving and unapproved or not cleared in vitro diagnostic device intended to identify a chemical, biological, radiological, or nuclear agent.
The number of laboratories (respondents) was changed (adjusted) to 150 laboratories that perform this type testing. Thus this adjustment resulted in an increase in the total burden estimate from 600 hours to 1350.
$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Saleda Perryman
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.